APA (7th ed.) Citation

Karakoyun, Ö., & Ayhan, E. (2026). Real-World Effectiveness and Safety of Upadacitinib Versus Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A Retrospective Cohort Study. Pharmaceuticals (14248247), 19(6), 828. https://doi.org/10.3390/ph19060828

Chicago Style (17th ed.) Citation

Karakoyun, Ömer, and Erhan Ayhan. "Real-World Effectiveness and Safety of Upadacitinib Versus Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A Retrospective Cohort Study." Pharmaceuticals (14248247) 19, no. 6 (2026): 828. https://doi.org/10.3390/ph19060828.

MLA (9th ed.) Citation

Karakoyun, Ömer, and Erhan Ayhan. "Real-World Effectiveness and Safety of Upadacitinib Versus Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A Retrospective Cohort Study." Pharmaceuticals (14248247), vol. 19, no. 6, 2026, p. 828, https://doi.org/10.3390/ph19060828.